Powassan virus: What the US Data Actually Shows

A rare tick-borne virus found in North America that can cause encephalitis (brain inflammation); most infections cause no symptoms, but severe cases can be life-threatening.

Figures current as of 2026-06-02 · Surveillance confidence: high · 4 of 5 US funnel metrics have a publishable figure

Established in the US A rare US tick-borne disease — tens of cases a year — mainly in the Northeast and Great Lakes regions.

The published figures

Every number below is reproduced from a primary source and carries that source beside it. Where a figure is absent it is shown as unavailable rather than estimated — the reasoning for each gap is set out further down this page.

MetricUnited StatesSourceAs of
Annual Exposure / Cases 60 CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source 2026-06-02
Severe Outcome Rate Data not available CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source 2026-06-02
Hospitalization Rate 92.2% CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) (hospitalizations ÷ reported cases, all disease cases 2004–2025) primary source 2026-06-02
Case Fatality Rate 13.2% CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) (deaths ÷ reported cases, all disease cases 2004–2025) primary source 2026-06-02
Annual Deaths 9 CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source 2026-06-02

case_fatality_rate_pct (13.2%) and hospitalization_rate_pct (92.2%) are §12a derivations from CDC's own ArboNET totals for all reported US Powassan disease cases 2004–2025 (63 deaths and 439 hospitalizations among 476 cases; data current as of June 2, 2026), superseding the 11% CDC 2006–2016 cohort figure and the 91.7% Tier 2 systematic-review figure, both retained as earlier history points. annual_deaths_estimate is the 2024 final count (9). severe_outcome_rate_pct left UNAVAILABLE: Powassan neuroinvasive disease is the only form nationally notifiable, so any 'severe outcome' percentage drawn from this surveillance stream would reflect ascertainment bias (mild/non-neuroinvasive infections are essentially never captured) rather than a true population rate.

How these figures were calculated

2 figures above are arithmetic rather than a number lifted straight from an agency page. Both inputs are given below with their own source, geography, and reporting period, so the calculation can be checked rather than taken on trust. A derived figure is never rated more reliable than its weakest input.

Hospitalization Rate

439 hospitalizations ÷ 476 reported cases × 100 = 92.2% (all US Powassan disease cases reported to ArboNET, 2004–2025)

InputValueGeographyPeriodSource
Numerator — Hospitalizations among reported US Powassan disease cases, 2004–2025 439 United States 2004–2025 (2025 preliminary) CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source
Denominator — Reported US Powassan disease cases, 2004–2025 476 United States 2004–2025 (2025 preliminary) CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source

Of reported US cases, 2004–2025 (CDC's own hospitalizations-by-year series, which it now publishes on this page). 2024 alone: 60 of 60 reported cases hospitalized. Replaces the Tier 2 figure of 91.7% (Kakoullis et al. 2023, 264 of 288 published cases 2004–2022), kept as the earlier history point. Because only neuroinvasive Powassan disease is reliably reported, this reflects the severe end of infection, not all infections.

Case Fatality Rate

63 deaths ÷ 476 reported cases × 100 = 13.2% (all US Powassan disease cases reported to ArboNET, 2004–2025)

InputValueGeographyPeriodSource
Numerator — Deaths among reported US Powassan disease cases, 2004–2025 63 United States 2004–2025 (2025 preliminary) CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source
Denominator — Reported US Powassan disease cases, 2004–2025 476 United States 2004–2025 (2025 preliminary) CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) primary source

Of reported US cases, 2004–2025 (CDC's own deaths-by-year series). 2024 alone: 9 of 60 (15.0%); 2025 preliminary: 10 of 76. Replaces the 11% figure (a CDC 2006–2016 cohort, 11 of 99 cases), kept as the earlier history point. Reported cases are predominantly severe neuroinvasive disease, so this overstates the fatality of infection overall.

What this data cannot tell you

1 of the five funnel metrics has no publishable US figure for Powassan virus. That is a deliberate result, not an oversight. Where no primary source publishes a comparable figure, this site leaves the cell empty rather than filling it with an estimate, a number borrowed from a different population, or a single-study result presented as a general rate.

  • Severe Outcome Rate — no comparable figure published by the record's primary source as of 2026-06-02.

This matters when comparing viruses. A blank cell is not a low number: it means the measurement does not exist, and treating it as zero would make Powassan virus look safer than the evidence supports. The comparison table on the Virus Risk Perspective page applies the same rule — unavailable figures are excluded from ranking rather than sorted to the bottom.

How Powassan virus compares

Ranked only against viruses in this collection that publish the same metric. Viruses without a published figure are excluded from each comparison rather than counted as zero, so the denominator differs from metric to metric.

Read the case comparison carefully. Records in this collection do not all measure exposure the same way. Some report confirmed cases counted by a surveillance system (measles, West Nile), others a modelled estimate of total annual illness including cases that are never reported (norovirus, seasonal influenza). A modelled burden figure will always dwarf a confirmed-case count, so a gap on this metric can reflect how a disease is counted as much as how often it occurs. The per-figure sources above state which basis each number uses.

Annual Exposure / Cases

At 60, Powassan virus is the lowest of the 11 viruses reporting this metric. Higher: Seasonal influenza, Norovirus, COVID-19.

Hospitalization Rate

At 92.2%, Powassan virus is the highest of the 5 viruses reporting this metric. Lower: West Nile virus, Dengue, Measles.

Case Fatality Rate

At 13.2%, 2 of the 9 other viruses reporting this metric are higher and 7 are lower. Higher: Rabies, Hantavirus. Lower: West Nile virus, Avian influenza A, COVID-19.

Annual Deaths

At 9, 5 of the 9 other viruses reporting this metric are higher and 4 are lower. Higher: Seasonal influenza, COVID-19, Respiratory syncytial virus. Lower: Dengue, Measles, Avian influenza A.

How the figures have moved

Each observation below is a figure as it stood on a given date, with the source that published it. Points are not interpolated: where an agency published a figure once, one point is shown rather than a line drawn through invented values.

Case Fatality Rate

As ofValueSeriesSource
2026-06-02 11% — CDC — Historic Data (2004-2025), Powassan Virus
2026-06-02 13.2% CDC ArboNET, all reported cases 2004–2025 CDC — Historic Data (2004-2025), Powassan Virus, ArboNET (data current as of June 2, 2026) (63 ÷ 476)

Sources

Sourcing tiers, and the rule that a derived figure inherits its weakest input's tier, are set out on the Our Sources page. The process behind every figure is described in How We Answer Questions.

Written and researched by Andy Wilcox, an independent researcher not a physician — his work is the product of disciplined primary-source research drawing on 30+ years as a consultant, operating executive, and investor. Nothing here is medical advice.

← Back to the full 15-virus comparison